EconPapers    
Economics at your fingertips  
 

Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile

Xinyun Cao, Hande Boyaci, James Chen, Yu Bao, Robert Landick () and Elizabeth A. Campbell ()
Additional contact information
Xinyun Cao: University of Wisconsin–Madison
Hande Boyaci: The Rockefeller University
James Chen: The Rockefeller University
Yu Bao: University of Wisconsin–Madison
Robert Landick: University of Wisconsin–Madison
Elizabeth A. Campbell: The Rockefeller University

Nature, 2022, vol. 604, issue 7906, 541-545

Abstract: Abstract Fidaxomicin (Fdx) is widely used to treat Clostridioides difficile (Cdiff) infections, but the molecular basis of its narrow-spectrum activity in the human gut microbiome remains unknown. Cdiff infections are a leading cause of nosocomial deaths1. Fidaxomicin, which inhibits RNA polymerase, targets Cdiff with minimal effects on gut commensals, reducing recurrence of Cdiff infection2,3. Here we present the cryo-electron microscopy structure of Cdiff RNA polymerase in complex with fidaxomicin and identify a crucial fidaxomicin-binding determinant of Cdiff RNA polymerase that is absent in most gut microbiota such as Proteobacteria and Bacteroidetes. By combining structural, biochemical, genetic and bioinformatic analyses, we establish that a single residue in Cdiff RNA polymerase is a sensitizing element for fidaxomicin narrow-spectrum activity. Our results provide a blueprint for targeted drug design against an important human pathogen.

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-022-04545-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:604:y:2022:i:7906:d:10.1038_s41586-022-04545-z

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-022-04545-z

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:604:y:2022:i:7906:d:10.1038_s41586-022-04545-z